Riluzole and olanzapine in Huntington's disease

被引：9

作者：

Bonelli, RM ^{[1
]}

Niederwieser, G ^{[1
]}

Diez, J ^{[1
]}

Költringer, P ^{[1
]}

机构：

[1] Hosp BHB Eggenberg, Dept Neurol & Psychiat, A-8021 Graz, Austria

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2002年 / 9卷 / 02期

关键词：

Huntington's disease; riluzole; olanzapine; chorea;

D O I：

10.1046/j.1468-1331.2002.0354f.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：183 / 184

页数：2

共 13 条

[1] SERUM HALOPERIDOL CONCENTRATION AND CHOREIFORM MOVEMENTS IN HUNTINGTONS-DISEASE [J].

BARR, AN ;

FISCHER, JH ;

KOLLER, WC ;

SPUNT, AL ;

SINGHAL, A .

NEUROLOGY, 1988, 38 (01) :84-88

[2]

CALABRESE VP, 1973, NEW ENGL J MED, V289, P104

[3] Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease [J].

Chen, M ;

Ona, VO ;

Li, MW ;

Ferrante, RJ ;

Fink, KB ;

Zhu, S ;

Bian, J ;

Guo, L ;

Farrell, LA ;

Hersch, SM ;

Hobbs, W ;

Vonsattel, JP ;

Cha, JHJ ;

Friedlander, RM .

NATURE MEDICINE, 2000, 6 (07) :797-+

[4] The use of olanzapine for movement disorder in Huntington's disease: a first case report [J].

Dipple, HC .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (01) :123-124

[5] EFFECT OF NEUROLEPTIC TREATMENT ON INVOLUNTARY MOVEMENTS AND MOTOR PERFORMANCES IN HUNTINGTONS-DISEASE [J].

GIROTTI, F ;

CARELLA, F ;

SCIGLIANO, G ;

GRASSI, MP ;

SOLIVERI, P ;

GIOVANNINI, P ;

PARATI, E ;

CARACENI, T .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1984, 47 (08) :848-852

[6] Improvement of Huntington's disease with olanzapine and valproate. [J].

Grove, VE ;

Quintanilla, J ;

DeVaney, GT .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13) :973-974

[7] Unified Huntington's disease rating scale: Reliability and consistency [J].

Kieburtz, K ;

Penney, JB ;

Como, P ;

Ranen, N ;

Shoulson, I ;

Feigin, A ;

Abwender, D ;

Greenamyre, JT ;

Higgins, D ;

Marshall, FJ ;

Goldstein, J ;

Steinberg, K ;

Shih, C ;

Richard, I ;

Hickey, C ;

Zimmerman, C ;

Orme, C ;

Claude, K ;

Oakes, D ;

Sax, DS ;

Kim, A ;

Hersch, S ;

Jones, R ;

Auchus, A ;

Olsen, D ;

BisseyBlack, C ;

Rubin, A ;

Schwartz, R ;

Dubinsky, R ;

Mallonee, W ;

Gray, C ;

Godfrey, N ;

Suter, G ;

Shannon, KM ;

Stebbins, GT ;

Jaglin, JA ;

Marder, K ;

Taylor, S ;

Louis, E ;

Moskowitz, C ;

Thorne, D ;

Zubin, N ;

Wexler, N ;

Swenson, MR ;

Paulsen, J ;

Swerdlow, N ;

Albin, R ;

Wernette, C ;

Walker, F ;

Hunt, V .

MOVEMENT DISORDERS, 1996, 11 (02) :136-142

[8] TETRABENAZINE HAS PROPERTIES OF A DOPAMINE RECEPTOR ANTAGONIST [J].

CRONIN, MJ ;

MACLEOD, RM .

ANNALS OF NEUROLOGY, 1982, 12 (03) :257-262

[9]

RANEN NG, 1993, PHYSICIANS GUIDE MAN

[10]

Rosas HD, 1999, MOVEMENT DISORD, V14, P326, DOI 10.1002/1531-8257(199903)14:2<326::AID-MDS1019>3.0.CO

← 1 2 →